Who are Iberogast® and Iberogast® N's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Canephron® N.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/iberogast-and-iberogast-n.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Iberogast® and Iberogast® N — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Iberogast® and Iberogast® N (Iberogast® and Iberogast® N) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal combination / Phytopharmaceutical. Area: Gastroenterology.

marketed Herbal combination / Phytopharmaceutical Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Iberogast® and Iberogast® N (Iberogast® and Iberogast® N) — Hospital Vall d'Hebron. Iberogast is a herbal combination product that promotes gastric motility and reduces visceral pain through multiple plant-derived active compounds.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Iberogast® and Iberogast® N TARGET	Iberogast® and Iberogast® N	Hospital Vall d'Hebron	marketed	Herbal combination / Phytopharmaceutical
Canephron® N	Canephron® N	Bionorica SE	phase 3	Herbal combination / Phytopharmaceutical

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal combination / Phytopharmaceutical class)

Bionorica SE · 1 drug in this class
Hospital Vall d'Hebron · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Iberogast® and Iberogast® N — Competitive Intelligence Brief. https://druglandscape.com/ci/iberogast-and-iberogast-n. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab